Stimulation of the CD2 receptor pathway induces apoptosis in human T lymphotropic virus type I-infected cell lines

被引:8
作者
Guyot, DJ
Trask, OJ
Andrews, JM
Newbound, GC
Lairmore, MD
机构
[1] OHIO STATE UNIV,DEPT VET BIOSCI,COLL VET MED,COLUMBUS,OH 43201
[2] OHIO STATE UNIV,CTR RETROVIRUS RES,COLUMBUS,OH 43201
[3] OHIO STATE UNIV,CTR COMPREHENS CANC,COLUMBUS,OH 43201
来源
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY | 1996年 / 11卷 / 04期
关键词
human T lymphotropic virus type I; apoptosis; CD2; CD3;
D O I
10.1097/00042560-199604010-00001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We demonstrate that CD2 receptor engagement, but not CD3 crosslinking, induces apoptosis in lymphocytes transformed by human T-cell lymphotropic virus type I (HTLV-I). Mitogenic pairs of anti-CD2 monoclonal antibodies inhibited [H-3]thymidine incorporation from 25 to 62% in CD2(+) HTLV-I-infected lymphocytes. This inhibition was associated with a 20-40% reduction in cell number and viability over a 3-day period, morphologic evidence of apoptosis, and irreversible DNA fragmentation. While cyclosporin A abrogated CD2-mediated proliferation in peripheral blood mononuclear cells, it had no effect on CD2-induced apoptosis in the HTLV-I-infected cell lines. Since HTLV-I is mitogenic to resting lymphocytes through CD2 activation pathways, these results suggest that HTLV-I-infected lymphocytes are primed for apoptosis following additional CD2 stimulation. This CD2-mediated apoptosis might be a factor in immune regulation of HTLV-I-associated diseases or might offer a novel adjunctive approach to treatment.
引用
收藏
页码:317 / 325
页数:9
相关论文
共 62 条
[1]   HTLV-1 TAX INDUCES CELLULAR PROTEINS THAT ACTIVATE THE KAPPA-B ELEMENT IN THE IL-2 RECEPTOR ALPHA-GENE [J].
BALLARD, DW ;
BOHNLEIN, E ;
LOWENTHAL, JW ;
WANO, Y ;
FRANZA, BR ;
GREENE, WC .
SCIENCE, 1988, 241 (4873) :1652-1655
[2]   THE EFFECT OF THE IMMUNOSUPPRESSANT FK-506 ON ALTERNATE PATHWAYS OF T-CELL ACTIVATION [J].
BIERER, BE ;
SCHREIBER, SL ;
BURAKOFF, SJ .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (02) :439-445
[3]  
BLATTNER WA, 1989, VIRAL INFECTIONS HUM, P545
[4]  
BOHMIG GA, 1994, J IMMUNOL, V152, P3720
[5]   PHYSICAL ASSOCIATION OF THE CYTOPLASMIC DOMAIN OF CD2 WITH THE TYROSINE KINASES P56(LCK) AND P59(FYN) [J].
CARMO, AM ;
MASON, DW ;
BEYERS, AD .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (09) :2196-2201
[6]  
CHLICHLIA K, 1995, ONCOGENE, V10, P269
[7]  
COHEN JJ, 1993, IMMUNOL TODAY, V14, P126, DOI 10.1016/0167-5699(93)90214-6
[8]   INHIBITION OF APOPTOSIS IN T-CELLS EXPRESSING HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I TAX [J].
COPELAND, KFT ;
HAAKSMA, AGM ;
GOUDSMIT, J ;
KRAMMER, PH ;
HEENEY, JL .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (10) :1259-1268
[9]   BOTH T-CELL RECEPTOR (TCR)-CD3 COMPLEX AND CD2 INCREASE THE TYROSINE KINASE-ACTIVITY OF P56(LCK) - CD2 CAN MEDIATE TCR-CD3-INDEPENDENT AND CD45-DEPENDENT ACTIVATION OF P56(LCK) [J].
DANIELIAN, S ;
ALCOVER, A ;
POLISSARD, L ;
STEFANESCU, M ;
ACUTO, O ;
FISCHER, S ;
FAGARD, R .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (11) :2915-2921
[10]  
DEBATIN KM, 1993, BLOOD, V81, P2972